About the Authors
- Candace H. Feldman
-
* E-mail: chfeldman@partners.org
Affiliation Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, United States of America
- Linda T. Hiraki
-
Affiliation Division of Rheumatology, The Hospital for Sick Children, Toronto, Canada
- Huichuan Lii
-
Affiliation Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital, Boston, Massachusetts, United States of America
- John D. Seeger
-
Affiliation Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital, Boston, Massachusetts, United States of America
- Seoyoung C. Kim
-
Affiliations Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, United States of America, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital, Boston, Massachusetts, United States of America
Competing Interests
Candace H. Feldman receives research funding from Pfizer Pharmaceuticals. This commercial source played no role in this study’s conception, design, analysis or presentation and does not alter adherence to all PLOS ONE policies. Linda T. Hiraki, Huichuan Lii, John D. Seeger, and Seoyoung C. Kim have no competing interests relevant to this article to disclose.
Author Contributions
Conceived and designed the experiments: CHF LTH HL JDS SCK. Analyzed the data: CHF LTH HL JDS SCK. Contributed reagents/materials/analysis tools: CHF LTH HL JDS SCK. Wrote the paper: CHF LTH HL JDS SCK.